BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//TYPO3/NONSGML Calendarize//EN
BEGIN:VEVENT
UID:calendarize-einladung-zur-hochschuloeffentlichen-disputation-von-massi
 mo-privitelli
DTSTAMP:20260908T084032Z
DTSTART:20260914T150000Z
DTEND:20260914T170000Z
SUMMARY:Einladung zur hochschulöffentlichen Disputation von Massimo Privi
 telli
DESCRIPTION:(For English\, see below)\nEinladung zur hochschulöffentliche
 n Disputation von Massimo Privitelli zum Thema:\n„Retrospective analysis
  of the influence of TP53\, STK11\, CDKN2A\, KEAP1 co-muta tions in EGFR o
 r KRAS G12C mutated non-small cell lung cancer (NSCLC) on clinical outcome
  parameters“.\nDatum: Montag\, 14.09.2026Uhrzeit: 15:00 UhrOrt: Besprech
 ungsraum Pius Hospital Heiligengeisthöfe 6\, 1. OG\nErstbetreuer: Prof. D
 r. Frank Griesinger (Universitätsklinik für Innere Medizin - Hämatologi
 e\, Department für Humanmedizin)\n-----\nInvitation to the university pub
 lic disputation by Massimo Privitelli on the topic:\n„Retrospective anal
 ysis of the influence of TP53\, STK11\, CDKN2A\, KEAP1 co-muta tions in EG
 FR or KRAS G12C mutated non-small cell lung cancer (NSCLC) on clinical out
 come parameters“.\nDate: Monday\, September\, 14\, 2026Time: 3:00 p.m.Ve
 nue: Meeting Room\, Pius Hospital\, Heiligengeisthöfe 6\, 1st Floor
X-ALT-DESC;FMTTYPE=text/html:<p><i>(For English\, see below)</i></p>\n<p>E
 inladung zur hochschulöffentlichen Disputation von <strong>Massimo Privit
 elli </strong>zum Thema:</p>\n<p><span lang="EN-GB" dir="ltr"><strong>„R
 etrospective analysis of the influence of TP53\, STK11\, CDKN2A\, KEAP1 co
 -muta tions in EGFR or KRAS G12C mutated non-small cell lung cancer (NSCLC
 ) on clinical outcome parameters“.</strong></span></p>\n<div><p><strong>
 Datum: </strong>Montag\, 14.09<strong>.</strong>2026<br /><strong>Uhrzeit:
 </strong> 15:00 Uhr<br /><strong>Ort:</strong> Besprechungsraum Pius Hospi
 tal Heiligengeisthöfe 6\, 1. OG</p>\n<p><strong>Erstbetreuer:</strong> Pr
 of. Dr. Frank Griesinger (Universitätsklinik für Innere Medizin - Hämat
 ologie\, Department für Humanmedizin)</p></div>\n<p><strong>-----</strong
 ></p>\n<p>Invitation to the university public disputation by<strong> Massi
 mo Privitelli </strong>on the topic:</p>\n<div style="margin-left:0px\;"><
 div style="margin-left:0px\;"><p><span lang="EN-GB" dir="ltr"><strong>„R
 etrospective analysis of the influence of TP53\, STK11\, CDKN2A\, KEAP1 co
 -muta tions in EGFR or KRAS G12C mutated non-small cell lung cancer (NSCLC
 ) on clinical outcome parameters“.</strong></span></p></div></div>\n<p><
 strong>Date: </strong>Monday<strong>\, </strong>September\, 14\, 2026<br /
 ><strong>Time: </strong>3:00 p.m.<br /><strong>Venue: </strong><span class
 ="Y2IQFc" lang="en" dir="ltr">Meeting Room\, Pius Hospital\, Heiligengeist
 höfe 6\, 1st Floor</span></p>
LOCATION:
END:VEVENT
END:VCALENDAR
